ABBOTT Company Profile

What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and eleven approved drugs.

Summary for ABBOTT

US Patents:	0
Tradenames:	89
Ingredients:	62
NDAs:	111

Drugs and US Patents for ABBOTT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019120-001	Oct 11, 1984		DISCN	No	No
Abbott	LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	018954-001	Jul 9, 1985		DISCN	No	No
Abbott	AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER	amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate	INJECTABLE;INJECTION	019712-001	Sep 8, 1988		DISCN	No	No
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-001	Aug 7, 1987		DISCN	No	No

Expired US Patents for ABBOTT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbott	LOPURIN	allopurinol	TABLET;ORAL	018297-002	Approved Prior to Jan 1, 1982	3,624,205
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-003	Aug 7, 1987	5,212,176
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-004	Aug 7, 1987	4,026,894
Abbott	NORVIR	ritonavir	CAPSULE;ORAL	020680-001	Mar 1, 1996	5,948,436*PED

Paragraph IV (Patent) Challenges for ABBOTT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	10 mg and 15 mg		2009-08-14
	Capsules	100 mg		2012-10-31
	Tablets	100 mg		2010-12-21

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Abbott
• Abbott Labs